ID   MARK4_HUMAN             Reviewed;         752 AA.
AC   Q96L34; Q8NG37; Q96JG7; Q96SQ2; Q9BYD8;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   05-OCT-2010, entry version 95.
DE   RecName: Full=MAP/microtubule affinity-regulating kinase 4;
DE            EC=2.7.11.1;
DE   AltName: Full=MAP/microtubule affinity-regulating kinase-like 1;
GN   Name=MARK4; Synonyms=KIAA1860, MARKL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Drewes G., Mandelkow E.M.;
RT   "MARK4, homologue of MARK1, MARK2 and MARK3.";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   MEDLINE=21226021; PubMed=11326310; DOI=10.1038/sj.neo.7900132;
RA   Kato T., Satoh S., Okabe H., Kitahara O., Ono K., Kihara C.,
RA   Tanaka T., Tsunoda T., Yamaoka Y., Nakamura Y., Furukawa Y.;
RT   "Isolation of a novel human gene, MARKL1, homologous to MARK3 and its
RT   involvement in hepatocellular carcinogenesis.";
RL   Neoplasia 3:4-9(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Beghini A., Magnani I., Roversi G., Piepoli T., DiTerlizzi S.,
RA   Pollo B., Conti A.M.F., Cowell J.K., Finocchiaro G., Larizza L.;
RT   "Neural progenitor-restricted isoform of MARKL1 gene is upregulated by
RT   19q13 amplification in human glioblastoma.";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   MEDLINE=21245130; PubMed=11347906; DOI=10.1093/dnares/8.2.85;
RA   Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XX.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 8:85-95(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26 AND THR-214, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [7]
RP   UBIQUITINATION, AND DEUBIQUITINATION BY USP9X.
RX   PubMed=18254724; DOI=10.1042/BJ20080067;
RA   Al-Hakim A.K., Zagorska A., Chapman L., Deak M., Peggie M.,
RA   Alessi D.R.;
RT   "Control of AMPK-related kinases by USP9X and atypical
RT   Lys(29)/Lys(33)-linked polyubiquitin chains.";
RL   Biochem. J. 411:249-260(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; THR-17; SER-23;
RP   SER-26; SER-423; SER-438 AND SER-545, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-377 AND CYS-418.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- INTERACTION:
CC       P60953:CDC42; NbExp=1; IntAct=EBI-302319, EBI-81752;
CC       Q9BYG4:PARD6G; NbExp=1; IntAct=EBI-302319, EBI-295417;
CC       Q8ND90:PNMA1; NbExp=1; IntAct=EBI-302319, EBI-302345;
CC       P41743:PRKCI; NbExp=1; IntAct=EBI-302319, EBI-286199;
CC       P04156:PRNP; NbExp=1; IntAct=EBI-302319, EBI-977302;
CC       Q15831:STK11; NbExp=2; IntAct=EBI-302319, EBI-306838;
CC       P23258:TUBG1; NbExp=1; IntAct=EBI-302319, EBI-302589;
CC       Q04917:YWHAH; NbExp=1; IntAct=EBI-302319, EBI-306940;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96L34-1; Sequence=Displayed;
CC       Name=2; Synonyms=MARKL1S;
CC         IsoId=Q96L34-2; Sequence=VSP_004946;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Isoform 2 is brain-specific.
CC   -!- PTM: Ubiquitinated with 'Lys-29'- and 'Lys-33'-linked
CC       polyubiquitins which appear to impede LKB1-mediated
CC       phosphorylation. Deubiquitinated by USP9X.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. MARK subfamily.
CC   -!- SIMILARITY: Contains 1 KA1 (kinase-associated) domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 UBA domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB47489.1; Type=Erroneous initiation;
CC       Sequence=BAB55238.1; Type=Erroneous initiation;
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MARK4ID419.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY057448; AAL23683.1; -; mRNA.
DR   EMBL; AB049127; BAB39380.1; -; mRNA.
DR   EMBL; AB088047; BAC03375.1; -; mRNA.
DR   EMBL; AY120867; AAM55491.1; -; mRNA.
DR   EMBL; AB058763; BAB47489.1; ALT_INIT; mRNA.
DR   EMBL; AK027619; BAB55238.1; ALT_INIT; mRNA.
DR   EMBL; AK075272; BAC11510.1; -; mRNA.
DR   IPI; IPI00064797; -.
DR   IPI; IPI00297959; -.
DR   RefSeq; NP_113605.2; -.
DR   UniGene; Hs.34314; -.
DR   ProteinModelPortal; Q96L34; -.
DR   SMR; Q96L34; 51-370, 652-752.
DR   IntAct; Q96L34; 42.
DR   STRING; Q96L34; -.
DR   PhosphoSite; Q96L34; -.
DR   PRIDE; Q96L34; -.
DR   Ensembl; ENST00000262891; ENSP00000262891; ENSG00000007047.
DR   GeneID; 57787; -.
DR   KEGG; hsa:57787; -.
DR   UCSC; uc002pbb.1; human.
DR   CTD; 57787; -.
DR   GeneCards; GC19P045754; -.
DR   HGNC; HGNC:13538; MARK4.
DR   MIM; 606495; gene.
DR   PharmGKB; PA30641; -.
DR   HOGENOM; HBG315019; -.
DR   HOVERGEN; HBG052453; -.
DR   InParanoid; Q96L34; -.
DR   OMA; TERPGSE; -.
DR   OrthoDB; EOG9NP9PH; -.
DR   PhylomeDB; Q96L34; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 64721; -.
DR   ArrayExpress; Q96L34; -.
DR   Bgee; Q96L34; -.
DR   CleanEx; HS_MARK4; -.
DR   Genevestigator; Q96L34; -.
DR   GermOnline; ENSG00000007047; Homo sapiens.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; NAS:UniProtKB.
DR   GO; GO:0043015; F:gamma-tubulin binding; IDA:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0050321; F:tau-protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0043130; F:ubiquitin binding; NAS:UniProtKB.
DR   GO; GO:0001578; P:microtubule bundle formation; IEP:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; IDA:UniProtKB.
DR   GO; GO:0043068; P:positive regulation of programmed cell death; NAS:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:UniProtKB.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR001772; Kinase-assoc_KA1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR020670; MAP/microtub-affin-reg_kin2/4.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR000449; UBA/transl_elong_EF1B_N.
DR   InterPro; IPR015940; UBA/transl_elong_EF1B_N_euk.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   PANTHER; PTHR22982:SF55; MAP/microtub-affin-reg_kin2/4; 1.
DR   Pfam; PF02149; KA1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00627; UBA; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SMART; SM00165; UBA; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50032; KA1; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN         1    752       MAP/microtubule affinity-regulating
FT                                kinase 4.
FT                                /FTId=PRO_0000086307.
FT   DOMAIN       59    310       Protein kinase.
FT   DOMAIN      324    368       UBA.
FT   DOMAIN      703    752       KA1.
FT   NP_BIND      65     73       ATP (By similarity).
FT   ACT_SITE    181    181       Proton acceptor (By similarity).
FT   BINDING      88     88       ATP (By similarity).
FT   MOD_RES       2      2       Phosphoserine.
FT   MOD_RES      17     17       Phosphothreonine.
FT   MOD_RES      23     23       Phosphoserine.
FT   MOD_RES      26     26       Phosphoserine.
FT   MOD_RES     214    214       Phosphothreonine.
FT   MOD_RES     423    423       Phosphoserine.
FT   MOD_RES     438    438       Phosphoserine.
FT   MOD_RES     545    545       Phosphoserine.
FT   VAR_SEQ     628    752       ADEPERIGGPEVTSCHLPWDQTETAPRLLRFPWSVKLTSSR
FT                                PPEALMAALRQATAAARCRCRQPQPFLLACLHGGAGGPEPL
FT                                SHFEVEVCQLPRPGLRGVLFRRVAGTALAFRTLVTRISNDL
FT                                EL -> TLDPSKRQNSNRCVSGASLPQGSKIRSQTNLRESG
FT                                DLRSQVAIYLGIKRKPPPGCSDSPGV (in isoform
FT                                2).
FT                                /FTId=VSP_004946.
FT   VARIANT     377    377       R -> Q (in dbSNP:rs35070611).
FT                                /FTId=VAR_040766.
FT   VARIANT     418    418       R -> C (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040767.
FT   CONFLICT     70     70       F -> S (in Ref. 2; BAB39380/BAC03375).
FT   CONFLICT    518    518       P -> L (in Ref. 5; BAB55238).
SQ   SEQUENCE   752 AA;  82520 MW;  4B430FFD2B150E7A CRC64;
     MSSRTVLAPG NDRNSDTHGT LGSGRSSDKG PSWSSRSLGA RCRNSIASCP EEQPHVGNYR
     LLRTIGKGNF AKVKLARHIL TGREVAIKII DKTQLNPSSL QKLFREVRIM KGLNHPNIVK
     LFEVIETEKT LYLVMEYASA GEVFDYLVSH GRMKEKEARA KFRQIVSAVH YCHQKNIVHR
     DLKAENLLLD AEANIKIADF GFSNEFTLGS KLDTFCGSPP YAAPELFQGK KYDGPEVDIW
     SLGVILYTLV SGSLPFDGHN LKELRERVLR GKYRVPFYMS TDCESILRRF LVLNPAKRCT
     LEQIMKDKWI NIGYEGEELK PYTEPEEDFG DTKRIEVMVG MGYTREEIKE SLTSQKYNEV
     TATYLLLGRK TEEGGDRGAP GLALARVRAP SDTTNGTSSS KGTSHSKGQR SSSSTYHRQR
     RHSDFCGPSP APLHPKRSPT STGEAELKEE RLPGRKASCS TAGSGSRGLP PSSPMVSSAH
     NPNKAEIPER RKDSTSTPNN LPPSMMTRRN TYVCTERPGA ERPSLLPNGK ENSSGTPRVP
     PASPSSHSLA PPSGERSRLA RGSTIRSTFH GGQVRDRRAG GGGGGGVQNG PPASPTLAHE
     AAPLPAGRPR PTTNLFTKLT SKLTRRVADE PERIGGPEVT SCHLPWDQTE TAPRLLRFPW
     SVKLTSSRPP EALMAALRQA TAAARCRCRQ PQPFLLACLH GGAGGPEPLS HFEVEVCQLP
     RPGLRGVLFR RVAGTALAFR TLVTRISNDL EL
//
